Welcome to the e-CCO Library Archive!
G. Fiorino1, L. Peyrin-Biroulet2, C. Bonifacio3, P. Naccarato1, G. Lo Bue3, A. Malesci4, O. Sociale1, L. Balzarini3, S. Danese1, 1IRCSS Humanitas, IBD Center, Rozzano, Italy, 2Nancy University Hospital, Iinserm U954, Nancy, France, 3IRCCS Humanitas, Radiology, Rozzano, Italy, 4IRCCS Humanitas, Gastroenterology and Digestive Endoscopy, Rozzano, Italy
Ionizing radiation exposure in patients with inflammatory bowel disease: Are we overexposing our patients?
M. Fekih*1, A. Laabidi2, L. Kallel2, R. Ben Jemaa2, N. Ben Mustapha2, M. Serghini2, J. Boubaker2, A. Filali2
1La Rabta hospital , Gastro enterology"A", Bab Saadoun, Tunisia, 2La Rabta hospital, Gastro enterology"A", Bab Saadoun, Tunisia
Is contrast-enhanced ultrasound (CE-US) superior to conventional ultrasonography (cUS) for the assessment of small bowel Crohn's disease inflammatory activity, as graded by magnetic resonance enterography (MRI)?
S. Boyer1, E. Guillot2, D. Marion2, G. Boschetti1, P.-J. Valette2, B. Flourié1, S. Nancey1, 1Hospices Civils de Lyon, Lyon-Sud hospital, Gastroenterology, Pierre Benite, France, 2Hospices Civils de Lyon, Lyon-Sud hospital, Radiology, Pierre Benite, France
G. Lang1, V. Nicolas2, L. Kübler2, W. Schmiegel1, T. Brechmann1, 1Ruhr-University-Bochum, Gastroenterology, Bochum, Germany, 2Ruhr-University-Bochum, Radiology, Bochum, Germany
Identification of risk factors of colitis-associated carcinoma in Japanese patients with Ulcerative Colitis: Results from a retrospective multicenter study in a Kyoto-Shiga cohort
T. Takagi*1, T. Yoshino2, S. Bamba3, K. Uchiyama1, Y. Naito1, M. Matsuura2, H. Nakase2, T. Tsujikawa3, A. Andoh3, T. Kogawa4
1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Kyoto University Hospital, Department of Gastroenterology and Hepatology, Kyoto, Japan, 3Shiga University of Medical Science, Department of Medicine, Otsu, Japan, 4Kogawa Internal Medicine Clinic, Internal Medicine Clinic, Kyoto, Japan
Is anemia a prognostic factor for disease behavior in IBD? – A Romanian National Register based evidence study
A. Lupu1, C. Cijevschi2, C. Mihai2, R. Iacob1, L. Gheorghe1, D. Dobru3, A. Tantau4, A. Goldis5, M. Ilie6, C. Gheorghe1, M. Ciocirlan1, M. Diculescu1, on behalf of the IBDPROSPECT Study Group, 1Fundeni Clinical Institute, Digestive Diseases and Liver Transplantation Center, Bucharest, Romania, 2Institute of Gastroenterology and Hepatology, Bd. Independentei, no. 1, Gastroenterology and Hepatology, Iasi, Romania, 3Municipal Hospital Targu Mures, Gastroenterology, Targu Mures, Romania, 43rd Medical Clinic Cluj-Napoca, Gastroenterology, Cluj-Napoca, Romania, 5University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania, 6Floreasca Emergency Hospital, Gastroenterology, Bucharest, Romania
F. Mocciaro1, R. Di Mitri1, S. Leone2, A. Calì1, A. Marino1, 1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy, 2CEO of AMICI, Palermo, Italy
Definitions of the endoscopic lesions in Crohn's disease: reproductibility study and GETAID expert consensus.
A. Buisson*1, 2, J. FILIPPI3, A. Amiot4, G. Cadiot5, M. Allez6, P. Marteau7, Y. Bouhnik8, G. Pineton de Chambrun9, A.-l. Pelletier10, S. Nancey11, D. Moussata11, A. Attar8, A. Blain12, L. Vuitton13, G. Vernier-Massouille14, P. Seksik15, M. Nachury16, J.-L. Dupas17, R. Modigliani6, L. Peyrin-Biroulet18, J.-Y. Mary19, E. Louis20
1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, 3Archet 2 University Hospital, Department of Gastroenterology, Nice, France, 4Hospital Henri-Mondor, Department of Gastroenterology, Creteil, France, 5University hospital of Reims, Gastroenterology, Reims, France, 6APHP, Hopital Saint Louis, Department of Gastroenterology, Paris, France, 7Hopital Lariboisiere, Gastroenterologie, Paris, France, 8Beaujon Hospital, Department of Gastroenterology, Clichy la Garenne, France, 9CHU de Montpellier, Department of Gastroenterology, Montpellier, France, 10APHP, Bichat Hospital, Gastroenterology Department, Paris, France, 11Hospices Civils de Lyon, Lyon-Sud hospital, Gastroenterology, Pierre Benite, France, 12APHP-IMM, Gastroenterology Department, Paris, France, 13University hospital of Besançon, Gastroenterology, Besançon, France, 14Tourcoing Hospital, Gastroenterology Department, Tourcoing, France, 15University Hospital of Saint Antoine, APHP, Gastroenterology, Paris, France, 16University hospital of Lille, Gastroenterology, Lille, France, 17Amiens University Hospital, Gastroenterology, Amiens, France, 18CHU Nancy Brabois, Department of Gastroenterology, Vandoeuvre les Nancy, France, 19University Paris VII, Biostatistics Department, Jussieu, France, 20CHU de Liege, Department of Gastroenterology, Liege, Belgium
Is depression associated with more emergency visits in inflammatory bowel disease?
G. Sirin, A. Celebi, O. Senturk, S. Hülagu, Kocaeli University, Gastroenterology, Kocaeli, Turkey
L. Kuznetsova1, S. Petrichuk1, I. Samohina1, A. Potapov2, E. Tsimbalova2, M. Venediktova2, 1Scientific Center of Children's Health, Cytochemical laboratory, Moscow, Russian Federation, 2Scientific Center of Children's Health, Gastroenterology department, Moscow, Russian Federation
Reproducibility of magnetic resonance enterography assessment of disease activity in Crohn's Disease using central readers
I. Ordas*1, J. Rimola1, G. Zou2, 3, C. Santillan4, K. Horsthuis5, S. Taylor6, J. Panes1, R. Khanna2, 7, J. Stoker8, L. Stitt2, G. D'Haens2, 9, W.J. Sandborn2, 10, B.G. Feagan2, 3, 7, M.K. Vandervoort2, B.G. Levesque2, 10
1Hospital Clinic de Barcelona, IDIBAPS and CIBERehd, Gastroenterology Unit, Barcelona, Spain, 2Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, 3University of Western Ontario, Department of Epidemiology and Biostatistics, London Ontario, Canada, 4University of California, UCSD Inflammatory Bowel Disease Center, San Diego CA, United States, 5Academic Medical Center, Inflammatory Bowel Disease Center, Amsterdam, Netherlands, 6University College London, Department of Medical Imaging, London, United Kingdom, 7University of Western Ontario, Department of Medicine, London , Canada, 8Academic Medical Center Amsterdam, Department of Internal Medicine, Amsterdam, Netherlands, 9University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands, 10University of California San Diego, Division of Gastroenterology, La Jolla, United States
Ipilimumab colitis: a GETAID multicentric study
L. Marthey1, C. Mateus2, M. Nachury3, S. Nancey4, F. Grange5, C. Zallot6, J.F. Rahier7, M. Bourdier de Beauregard8, L. Peyrin-Biroulet6, L. Mortier9, C. Robert2, F. Carbonnel10, 1Beclere Hospital, Gastroenterology, Clamart, France, 2Gustave Roussy Institute, Dermatology, Villejuif, France, 3Huriez Hospital, Gastroenterology, Lille, France, 4Lyon Sud Hospital, Gastroenterology, Pierre Benite, France, 5Debre Hospital, Dermatology, Reims, France, 6Brabois Hospital, Gastroenterology, Vandoeuvre les Nancy, France, 7Mont Godinne Hospital, Gastroenterology, Yvoir, Belgium, 8Minjoz Hospital, Gastroenterology, Besançon, France, 9Huriez Hospital, Dermatology, Lille, France, 10Bicetre Hospital, Gastroenterology, Kremlin-Bicetre, France